Meag Munich Ergo’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,141
Closed -$1.91M 271
2021
Q2
$1.91M Buy
+4,141
New +$1.67M 0.18% 125
2020
Q1
Sell
-2,372
Closed -$757K 354
2019
Q4
$757K Sell
2,372
-7,465
-76% -$2.26M 0.08% 223
2019
Q3
$2.87M Buy
9,837
+4,101
+71% +$1.21M 0.15% 155
2019
Q2
$1.99M Hold
5,736
0.16% 149
2019
Q1
$1.7M Sell
5,736
-4,033
-41% -$1.18M 0.14% 173
2018
Q4
$2.85M Buy
+9,769
New +$3.03M 0.35% 77
2018
Q3
Sell
-11,565
Closed -$3.13M 406
2018
Q2
$3.13M Buy
11,565
+6,748
+140% +$1.72M 0.19% 162
2018
Q1
$1.1M Sell
4,817
-10,426
-68% -$2.39M 0.04% 322
2017
Q4
$3.24M Buy
+15,243
New +$3.14M 0.13% 205

Other funds holding ILMN

Meag Munich Ergo's ILMN Position: Q3 2021 in Review

Meag Munich Ergo sold out of Illumina (ILMN) in Q3 2021, closing a stake of 4,141 shares — an estimated $1.91M sold.

Meag Munich Ergo first reported a position in ILMN in Q4 2017 and held it in 9 quarters. The position peaked at $3.24M in Q4 2017. 1,072 funds tracked by Wall St. Rank hold ILMN as of Q3 2021.

  • Meag Munich Ergo reported no remaining Illumina position as of Q3 2021 after selling out during the quarter.
  • Meag Munich Ergo sold 4,141 Illumina shares in Q3 2021, an estimated $1.91M.
  • Meag Munich Ergo first reported a position in Illumina in Q4 2017 and held it in 9 quarters.
  • Meag Munich Ergo's Illumina position peaked at $3.24M in Q4 2017.
  • 1,072 funds tracked by Wall St. Rank held Illumina as of Q3 2021.

Based on Meag Munich Ergo's 13F filing for Q3 2021, filed 13 Oct 2021.